HMGCS2 protein expression was significantly reduced in prostate cancer tissues, and low HMGCS2 expression was associated with a high Gleason score, pathological grade, and presence of distant metastasis in prostate cancer [26]. The gene discussed is HMGCS2; the disease is prostate carcinoma.